Shkreli’s former company pays $40m in price-gouging settlementA pharma company formerly led by ‘pharma bro’ Martin Shkreli has settled a long-running lawsuit with the US Share XShkreli’s former company pays $40m in price-gouging settlementhttps://pharmaphorum.com/news/shkrelis-former-company-pays-40m-in-price-gouging-settlement/
Pharma price gouging: lessons from the US and UKLoopholes which allow companies to exploit generic drug prices are being closed down in the UK – but the Share XPharma price gouging: lessons from the US and UKhttps://pharmaphorum.com/views-and-analysis/pharma-price-gouging-lessons-us-uk/
Concordia at centre of drug pricing probeSpeciality generics company Concordia has confirmed that it is under investigation from the UK’s competition watchdog over the Share XConcordia at centre of drug pricing probehttps://pharmaphorum.com/news/concordia-centre-drug-pricing-probe/
